Hologic (NASDAQ:HOLX – Get Free Report) had its target price upped by equities researchers at Raymond James from $85.00 to $88.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the medical equipment provider’s stock. Raymond James’ price objective suggests a potential upside of 20.86% […]
Hologic (NASDAQ:HOLX – Get Free Report) updated its second quarter earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.95 to $1.00 for the period, compared to the consensus estimate of $0.98. The company issued revenue guidance of $990 million to $1.010 billion, compared to the consensus revenue estimate of $994.39 […]
Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.950-1.000 for the period, compared to the consensus earnings per share estimate of 0.980. The company issued revenue guidance of $990.0 million-$1.0 billion, compared to the consensus revenue […]
Hologic, Inc. (NASDAQ:HOLX – Get Free Report) CFO Karleen Marie Oberton sold 14,940 shares of the company’s stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $75.00, for a total value of $1,120,500.00. Following the completion of the sale, the chief financial officer now owns […]
Hologic (NASDAQ:HOLX – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.950-1.000 for the period, compared to the consensus estimate of 0.980. The company issued revenue guidance of $990.0 million-$1.0 billion, compared to the consensus revenue estimate of […]